Arena Pharmaceuticals, Inc. (ARNA)

[mick]

http://finviz.com/quote.ashx?t=arna

Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.

The company offers BELVIQ, a drug candidate approved by the United States food and drug administration for chronic weight management in adults. It is also involved in the development of APD811, an agonist of the prostacyclin receptor, which is in Phase I clinical trials for the treatment of pulmonary arterial hypertension; and temanogrel, an inverse agonist of the serotonin 2A receptor that is in Phase I clinical trials for the treatment of thrombotic diseases.

In addition, the company's preclinical development products comprise APD334, an agonist of the S1P1 receptor intended for the treatment of autoimmune diseases; APD371, an agonist of the cannabinoid receptor 2 intended for the treatment of pain; and GPR119 agonists intended for the treatment of type 2 diabetes. Further, it manufactures drug products under a manufacturing services agreement.

The company has a marketing and supply agreement with Ildong Pharmaceutical Co., Ltd. for the commercialization of BELVIQ in South Korea. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.

13-Jan-14 10:19AM J.P. Morgan Healthcare Confab Live Blog: Day One at TheStreet +7.37%
08:32AM ARENA PHARMACEUTICALS INC Files SEC form 8-K, Other Events EDGAR Online
10-Jan-14 03:07PM Arena Marches Up - Belviq Sales Show Traction at Seeking Alpha +5.12%
09-Jan-14 08:59AM Healthcare Picks By Drug Type In 2014 at Seeking Alpha
08:59AM Healthcare Picks By Drug Type In 2014
07-Jan-14 12:39AM Arena's Belviq Closes Out 2013; Begins 2014 at Seeking Alpha
12:39AM Arena's Belviq Closes Out 2013; Begins 2014
06-Jan-14 05:09PM Obesity Stocks Focus On Approvals As Arena Pharmaceuticals Goes Global at TheStreet
05:09PM Obesity Stocks Focus On Approvals As Arena Pharmaceuticals Goes Global
08:00AM Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference PR Newswire
08:00AM Arena Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
04-Jan-14 01:25PM The 7 Healthiest Countries in the World at Motley Fool
01:25PM The 7 Healthiest Countries in the World
03-Jan-14 08:30AM Biotech Stocks Under $10 With Huge Upside Potential for 2014 at 24/7 Wall St.
08:30AM Biotech Stocks Under $10 With Huge Upside Potential for 2014
02-Jan-14 01:42PM What Lies Ahead For Arena Pharmaceuticals? at Seeking Alpha
01:42PM What Lies Ahead For Arena Pharmaceuticals?
12:09PM Vivus Scores Insurance Win at Seeking Alpha
01-Jan-14 12:26PM 3 Drugs That Increased Their Potential in 2013 at Motley Fool
12:26PM 3 Drugs That Increased Their Potential in 2013